• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.

作者信息

Oliva Alessandra, D'Abramo Alessandra, D'Agostino Claudia, Iannetta Marco, Mascellino Maria T, Gallinelli Carmela, Mastroianni Claudio M, Vullo Vincenzo

机构信息

Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università, Piazzale Aldo Moro, 00185 Rome, Italy.

Dipartimento di Sanità Pubblica e Malattie Infettive, Sapienza Università, Piazzale Aldo Moro, 00185 Rome, Italy UOC Malattie Infettive, Fondazione Eleonora Lorillard Spencer Cenci, Sapienza Università, Corso della Repubblica, 04100 Latina, Italy

出版信息

J Antimicrob Chemother. 2014 Jun;69(6):1718-20. doi: 10.1093/jac/dku027. Epub 2014 Feb 11.

DOI:10.1093/jac/dku027
PMID:24521856
Abstract
摘要

相似文献

1
Synergistic activity and effectiveness of a double-carbapenem regimen in pandrug-resistant Klebsiella pneumoniae bloodstream infections.双碳青霉烯类方案治疗泛耐药肺炎克雷伯菌血流感染的协同活性及有效性
J Antimicrob Chemother. 2014 Jun;69(6):1718-20. doi: 10.1093/jac/dku027. Epub 2014 Feb 11.
2
Therapeutic strategy for pandrug-resistant Klebsiella pneumoniae severe infections: short-course treatment with colistin increases the in vivo and in vitro activity of double carbapenem regimen.泛耐药肺炎克雷伯菌严重感染的治疗策略：多黏菌素短程治疗可增强双碳青霉烯类方案的体内外活性。
Int J Infect Dis. 2015 Apr;33:132-4. doi: 10.1016/j.ijid.2015.01.011. Epub 2015 Jan 15.
3
Effectiveness of a double-carbapenem regimen for infections in humans due to carbapenemase-producing pandrug-resistant Klebsiella pneumoniae.产碳青霉烯酶泛耐药肺炎克雷伯菌所致人类感染应用双联碳青霉烯类方案的疗效。
Antimicrob Agents Chemother. 2013 May;57(5):2388-90. doi: 10.1128/AAC.02399-12. Epub 2013 Feb 25.
4
Clinical outcome of dual colistin- and carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A single-center retrospective study of 75 cases in India.印度单中心回顾性研究：75 例碳青霉烯类和多黏菌素类耐药肺炎克雷伯菌血流感染的临床转归。
Am J Infect Control. 2017 Nov 1;45(11):1289-1291. doi: 10.1016/j.ajic.2017.06.028. Epub 2017 Aug 12.
5
Impact of carbapenem resistance on the outcome of patients' hospital-acquired bacteraemia caused by Klebsiella pneumoniae.碳青霉烯类耐药对肺炎克雷伯菌引起的医院获得性菌血症患者结局的影响。
J Hosp Infect. 2013 Apr;83(4):307-13. doi: 10.1016/j.jhin.2012.10.012. Epub 2013 Jan 10.
6
Treatment Outcome of Bacteremia Due to Non-Carbapenemase-producing Carbapenem-Resistant Klebsiella pneumoniae Bacteremia: Role of Carbapenem Combination Therapy.产非碳青霉烯酶碳青霉烯类耐药肺炎克雷伯菌血症的治疗转归：碳青霉烯类联合治疗的作用。
Clin Ther. 2020 Mar;42(3):e33-e44. doi: 10.1016/j.clinthera.2020.01.004. Epub 2020 Feb 12.
7
Mortality Associated with Bacteremia Due to Colistin-Resistant Klebsiella pneumoniae with High-Level Meropenem Resistance: Importance of Combination Therapy without Colistin and Carbapenems.高产碳青霉烯酶耐药肺炎克雷伯菌引起的粘菌素耐药菌血症相关死亡率：不使用粘菌素和碳青霉烯类药物联合治疗的重要性。
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00406-17. Print 2017 Aug.
8
Successful Treatment of Carbapenemase-Producing Pandrug-Resistant Klebsiella pneumoniae Bacteremia.产碳青霉烯酶的泛耐药肺炎克雷伯菌菌血症的成功治疗
Antimicrob Agents Chemother. 2015 Oct;59(10):5903-8. doi: 10.1128/AAC.00655-15.
9
Successful ertapenem-doripenem combination treatment of bacteremic ventilator-associated pneumonia due to colistin-resistant KPC-producing Klebsiella pneumoniae.厄他培南-多黏菌素联合治疗耐黏菌素产KPC肺炎克雷伯菌所致菌血症性呼吸机相关性肺炎成功案例
Antimicrob Agents Chemother. 2013 Jun;57(6):2900-1. doi: 10.1128/AAC.00188-13. Epub 2013 Apr 9.
10
Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections.多药耐药肺炎克雷伯菌血流感染患者的死亡预测因素。
Expert Rev Anti Infect Ther. 2013 Oct;11(10):1053-63. doi: 10.1586/14787210.2013.836057. Epub 2013 Sep 27.

引用本文的文献

1
Ceftazidime-Avibactam Plus Aztreonam for the Treatment of Blood Stream Infection Caused by Resistant to All Beta-Lactame/Beta-Lactamase Inhibitor Combinations.头孢他啶-阿维巴坦联合氨曲南治疗对所有β-内酰胺类/β-内酰胺酶抑制剂组合耐药的血流感染
Antibiotics (Basel). 2025 Aug 7;14(8):806. doi: 10.3390/antibiotics14080806.
2
Characterization of sulopenem antimicrobial activity using time-kill kinetics, synergy, post-antibiotic effect, and sub-inhibitory MIC effect methods against and isolates.使用时间杀菌动力学、协同作用、抗生素后效应和亚抑菌MIC效应方法对[具体菌种]分离株进行舒洛培南抗菌活性的表征。
Microbiol Spectr. 2025 Mar 4;13(3):e0189824. doi: 10.1128/spectrum.01898-24. Epub 2025 Feb 5.
3
In vitro evaluation of dual carbapenem combinations against carbapenemase-producing Pseudomonas aeruginosa.
针对产碳青霉烯酶铜绿假单胞菌的双碳青霉烯类联合用药的体外评估
J Antimicrob Chemother. 2025 Feb 3;80(2):593-595. doi: 10.1093/jac/dkae445.
4
Plant-Origin Components: New Players to Combat Antibiotic Resistance in .植物源成分：应对抗生素耐药性的新武器
Int J Mol Sci. 2024 Feb 10;25(4):2134. doi: 10.3390/ijms25042134.
5
Meropenem plus Ertapenem and Ceftazidime-Avibactam plus Aztreonam for the Treatment of Ventilator Associated Pneumonia Caused by Pan-Drug Resistant .美罗培南联合厄他培南以及头孢他啶-阿维巴坦联合氨曲南用于治疗泛耐药菌引起的呼吸机相关性肺炎
Antibiotics (Basel). 2024 Jan 31;13(2):141. doi: 10.3390/antibiotics13020141.
6
The Effect of Double Carbapenem Regimen in the Management of Carbapenem-Resistant Klebsiella pneumoniae Infections: A Report of Five Cases.双碳青霉烯方案治疗耐碳青霉烯肺炎克雷伯菌感染的疗效：5例报告
Cureus. 2024 Jan 10;16(1):e52023. doi: 10.7759/cureus.52023. eCollection 2024 Jan.
7
Carbapenem Combinations for Infections Caused by Carbapenemase-Producing : Experimental In Vitro and In Vivo Analysis.用于产碳青霉烯酶菌感染的碳青霉烯类联合用药：体外和体内实验分析
Antibiotics (Basel). 2022 Sep 7;11(9):1212. doi: 10.3390/antibiotics11091212.
8
Infectious disease: how to manage Gram-positive and Gram-negative pathogen conundrums with dual beta-lactam therapy.传染病：如何通过双β-内酰胺疗法应对革兰氏阳性菌和革兰氏阴性菌病原体难题。
Drugs Context. 2022 Jan 20;11. doi: 10.7573/dic.2021-8-9. eCollection 2022.
9
In vitro Combined Inhibitory Activities of β-Lactam Antibiotics and Clavulanic Acid Against -Positive .β-内酰胺类抗生素与克拉维酸对革兰氏阳性菌的体外联合抑制活性
Infect Drug Resist. 2021 Feb 2;14:361-368. doi: 10.2147/IDR.S292612. eCollection 2021.
10
Mortality of Pandrug-Resistant Bloodstream Infections in Critically Ill Patients: A Retrospective Cohort of 115 Episodes.重症患者泛耐药血流感染的死亡率：115例回顾性队列研究
Antibiotics (Basel). 2021 Jan 15;10(1):76. doi: 10.3390/antibiotics10010076.